Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
4
|
pubmed:dateCreated |
1983-4-7
|
pubmed:abstractText |
The bioavailability of quinidine sulfate after oral administration of a commercial sustained-release quinidine tablet was compared with that of oral quinidine sulfate solution in 18 normal subjects. Three hundred milligrams of each product was administered to each subject in standard cross-over fashion on separate occasions, with plasma quinidine levels measured for 46 h after each dose. Although peak plasma quinidine levels were lower, and occurred later, after tablet administration than after solution, analysis of the area under the plasma quinidine level-time curve (AUC) values for each product indicated that the products were equivalent, in terms of the extent of absorption, with the mean AUC (0-46 h) value for the tablet, 8744 . 4 ng x h ml-1, comparable to that of the solution, 9145 . 9 ng x h ml-1.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
0142-2782
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
3
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
301-10
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:7159686-Administration, Oral,
pubmed-meshheading:7159686-Adult,
pubmed-meshheading:7159686-Biological Availability,
pubmed-meshheading:7159686-Delayed-Action Preparations,
pubmed-meshheading:7159686-Female,
pubmed-meshheading:7159686-Humans,
pubmed-meshheading:7159686-Kinetics,
pubmed-meshheading:7159686-Male,
pubmed-meshheading:7159686-Quinidine,
pubmed-meshheading:7159686-Random Allocation,
pubmed-meshheading:7159686-Solutions
|
pubmed:articleTitle |
Bioavailability of a commercial sustained-release quinidine tablet compared to oral quinidine solution.
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
Randomized Controlled Trial
|